Volitionrx (VNRX) Cash from Operations Growth (3y) (2014 - 2025)
Volitionrx (VNRX) Cash from Operations Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 0.50% |
| 10 | Volitionrx | 92,854.63 | -1.02 Mn | - | 1.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.82% |
| Sep 30, 2025 | 18.95% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | -47.21% |
| Dec 31, 2024 | -7.20% |
| Sep 30, 2024 | -3.36% |
| Jun 30, 2024 | -7.62% |
| Mar 31, 2024 | -10.61% |
| Dec 31, 2023 | 63.34% |
| Sep 30, 2023 | -23.22% |
| Jun 30, 2023 | -18.36% |
| Mar 31, 2023 | -22.14% |
| Dec 31, 2022 | -30.72% |
| Sep 30, 2022 | -22.41% |
| Jun 30, 2022 | -31.23% |
| Mar 31, 2022 | 44.05% |
| Dec 31, 2021 | -6.71% |
| Sep 30, 2021 | -1.88% |
| Jun 30, 2021 | -21.87% |
| Mar 31, 2021 | -20.69% |